WebApr 17, 2024 · In late March, a federal judge dismissed a whistleblower lawsuit against Novartis AG that accused the company of engaging in a kickback scheme to pay doctors to prescribe its multiple sclerosis drug Gilenya. The lawsuit, originally filed by former Novartis sales representative Stephen Camburn, was backed by federal prosecutors and 28 state ...
Novartis forced to face claims it fired employee for raising Gilenya ...
WebMay 4, 2015 · For five years until 2012, Novartis orchestrated a scheme whereby it offered kickbacks, in the form of patient referrals and other benefits to certain specialty pharmacies, including Accredo and Bioscrip, in exchange for increasing their Exjade refills through biased recommendations to patients. WebNovartis $370 Million Medicaid Fraud Settlement - Alleged Kickback Scheme on High-priced Prescription Drugs. November 20, 2015. Novartis Pharmaceuticals has agreed to pay $370 million dollars after admitting responsibility for offering kickbacks to pharmacies that consistently recommended high-price prescription drugs Exjade and Myfortic. diagnostic tests for bladder cancer
Novartis kickback case settlement will cost Express …
WebAug 11, 2016 · Novartis, a Swiss pharmaceutical giant, has been fined 55.1 billion won ($49 million) and given a six-month suspension of insurance benefits on its nine medicines over available he... WebJul 20, 2024 · To resolve these kickback allegations, Novartis agreed to pay $591,442,008 back to Federal healthcare programs and to pay $48,151,273 to settle state Medicaid … WebJan 22, 2014 · The lawsuit alleges Novartis launched its kickback scheme in 2007, when it became concerned that patients were discontinuing use of Exjade because of side effects. The government alleges Novartis provided the kickbacks to induce BioScrip to try to keep patients on the drug as long as possible. cinnaminson public schools nj